...Seek and Pernix terminated a 2010 JV to develop Pernix's BC1036 to treat persistent cough and...
...on OTC and prescription products. Seek plans to start a European Phase III trial of BC1036...
...to BC1036 because of interest shown within the pharmaceutical industry. The non-narcotic anti-tussive based on theobromine...

...theobromine ( BC1036 ). The companies decided to auction rights to non-narcotic anti-tussive based on theobromine...
...will not affect its plans to conduct a Phase III trial in Europe next half. BC1036...

...Seek and Pernix formed a JV to develop BC1036 to treat persistent cough. The JV will...
...JV will conduct a Phase III trial in Europe of the non-narcotic anti-tussive based on theobromine...
...expected to begin in 1H11. Both companies will also contribute any IP related to theobromine. BC1036...